Drug Profile
BB 001
Alternative Names: Id-CpG-Capsid vaccineLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Bullet Biotechnology
- Class Cancer vaccines; Immunotherapies; Virus-like particle vaccines
- Mechanism of Action Immunostimulants; Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported B-cell lymphoma
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in B-cell lymphoma in USA
- 05 Jul 2016 Preclinical development is ongoing in USA
- 12 Sep 2013 Preclinical trials in B-cell lymphoma in USA (unspecified route)